Bliss GVS Pharma Board of Directors

Get the latest insights into the leadership at Bliss GVS Pharma. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Aditi BhattCompany Secretary & Compliance Officer
Nandkumar chodankarChairman
Santosh ParabNon Executive Independent Director
Shilpa BhatiaNon Executive Independent Woman Director

Bliss GVS Pharma Share price

BLISSGVS

273.59

14.78 (5.71%)
NSE
BSE
Last updated on 22 Apr, 2026 | 15:59 IST
Today's High

276.95

Today's Low

260.00

52 Week Low

109.03

52 Week High

276.95

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Bliss GVS Pharma FAQs

The board at Bliss GVS Pharma consists of experienced professionals, including Aditi Bhatt, Nandkumar chodankar, and others, overseeing the company’s strategic and corporate governance.

Directors at Bliss GVS Pharma are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Aditi Bhatt is the current chairman at Bliss GVS Pharma.

Executive directors at Bliss GVS Pharma are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Bliss GVS Pharma adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Bliss GVS Pharma, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost